Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?, Vascular Health and Risk Management, January 2016, Dove Medical Press,
DOI: 10.2147/vhrm.s96971.
You can read the full text:

Open access logo


The following have contributed to this page